|
US State Market Index: Venoms
|
| BizMiner | 12 pages | Juillet 2006 | Anglais
| |
The metrics in this report cover three year trends in Venoms [Manufacturing sector], broken out on a state-by-state basis.
Analysis is based on data applied from 1 industry firms.
Industry marke ... |
475,00 € |
| |
| |
|
|
| |
|
|
Disease and Therapy Review: Hepatitis C
|
| Timely Data Resources | 7 pages | Janvier 2007 | Anglais
| |
The Hepatitis C Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, and an overview of treatments.
Dosing information and treatment c ... |
720,00 € |
| |
| |
|
|
| |
|
|
Lower Detection Limits of HBV DNA Assays
|
| TriMark | 1 page | Janvier 2006 | Anglais
| |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ... |
80,00 € |
| |
| |
|
|
| |
|
|
Human Vaccines
|
| Global Industry Analysts, Inc. | 481 pages | Octobre 2005 | Anglais
| |
This report analyzes the worldwide markets for Human Vaccines in Millions of US$.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Jap ... |
3.091,00 € |
| |
| |
|
|
| |
|
|
|
|
Monoclonal Antibody Therapies: Sector Analysis Tool
|
| Datamonitor | pages | Avril 2005 | Anglais
| |
IntroductionThe mAb Sector Analysis Tool presents the marketed and R&D portfolios, technology focus and product development strategies of over 100 key players in the mAbs market.
In addition, you c ... |
6.080,00 € |
| |
| |
|
|
| |
|
|
HIV/AIDS Testing
|
| Global Industry Analysts, Inc. | 323 pages | Août 2006 | Anglais
| |
This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands of Units.
The Product segments analyzed include HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Moni ... |
2.360,00 € |
| |
| |
|
|
| |
|
|
Vaccines
|
| Cygnus Business Consulting & Research | 143 pages | Mars 2008 | Anglais
| |
Vaccine manufacturers from all over the world have been involved in a stalemate with governments regarding supply and demand.
While governments are reluctant to ensure steady demand for vaccines un ... |
600,00 € |
| |
| |
|
|
| |
|
|
|
|
|
